0
0
0
EPCS 2.0 Act
12/7/2023, 5:06 PM
Summary of Bill S 2666
Bill 118 s 2666, also known as the EPCS 2.0 Act, is a piece of legislation currently being considered by the US Congress. The main purpose of this bill is to enhance the security and efficiency of electronic prescribing of controlled substances (EPCS) in the United States.
The EPCS 2.0 Act aims to address the growing concerns surrounding the misuse and abuse of controlled substances by requiring healthcare providers to use electronic prescribing systems that meet certain security standards. This will help to prevent fraudulent prescriptions and ensure that patients receive the correct medications in a timely manner.
Additionally, the bill includes provisions to improve interoperability between different electronic health record systems, making it easier for healthcare providers to access and share patient information securely. This will help to streamline the prescribing process and reduce the risk of errors or delays in patient care. Overall, the EPCS 2.0 Act is designed to modernize and strengthen the electronic prescribing system for controlled substances in the United States, with the ultimate goal of improving patient safety and reducing the potential for abuse and misuse of these medications.
The EPCS 2.0 Act aims to address the growing concerns surrounding the misuse and abuse of controlled substances by requiring healthcare providers to use electronic prescribing systems that meet certain security standards. This will help to prevent fraudulent prescriptions and ensure that patients receive the correct medications in a timely manner.
Additionally, the bill includes provisions to improve interoperability between different electronic health record systems, making it easier for healthcare providers to access and share patient information securely. This will help to streamline the prescribing process and reduce the risk of errors or delays in patient care. Overall, the EPCS 2.0 Act is designed to modernize and strengthen the electronic prescribing system for controlled substances in the United States, with the ultimate goal of improving patient safety and reducing the potential for abuse and misuse of these medications.
Read the Full Bill
Current Status of Bill S 2666
Bill S 2666 is currently in the status of Bill Introduced since July 27, 2023. Bill S 2666 was introduced during Congress 118 and was introduced to the Senate on July 27, 2023. Bill S 2666's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of July 27, 2023
Bipartisan Support of Bill S 2666
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
2Democrat Cosponsors
0Republican Cosponsors
2Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 2666
Primary Policy Focus
HealthAlternate Title(s) of Bill S 2666
EPCS 2.0 Act
EPCS 2.0 Act
Electronic Prescribing for Controlled Substances Act
A bill to amend the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to provide for requirements for electronic-prescribing for controlled substances under group health plans and group and individual health insurance coverage.
Comments
Sponsors and Cosponsors of S 2666
Latest Bills
Save the World Cup Act
Bill HR 7986April 4, 2026
Safe Passage to the World Cup Act
Bill HR 7988April 4, 2026
Addressing Teacher Shortages Act of 2026
Bill S 4025April 3, 2026
To amend the Securities Exchange Act of 1934 to repeal certain disclosure requirements related to conflict minerals, and for other purposes.
Bill HR 7085April 3, 2026
BETS OFF Act
Bill HR 7955April 3, 2026
BETS OFF Act
Bill S 4115April 3, 2026
Vote Without Fear Act
Bill S 4121April 3, 2026
Sentencing Commission Improvements Act
Bill S 4136April 3, 2026
GAAME Act of 2026
Bill S 4018April 3, 2026
A resolution designating March 21, 2026, as "National Osceola Turkey Day".
Bill SRES 647April 3, 2026
SUPPORT for Patients and Communities Reauthorization Act
Bill S 3393March 5, 2024

